Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biomerica (BMRA) Net Margin (2016 - 2026)

Biomerica's Net Margin history spans 17 years, with the latest figure at 132.93% for Q1 2026.

  • Quarterly results put Net Margin at 132.93% for Q1 2026, down 2900.0% from a year ago — trailing twelve months through Feb 2026 was 96.49% (down 1255.0% YoY), and the annual figure for FY2025 was 93.64%, up 1521.0%.
  • Net Margin for Q1 2026 was 132.93% at Biomerica, down from 109.09% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 0.14% in Q3 2025 to a low of 206.14% in Q2 2025.
  • The 5-year median for Net Margin is 109.09% (2025), against an average of 102.03%.
  • The sharpest move saw Net Margin skyrocketed 12918bps in 2022, then tumbled -14716bps in 2023.
  • Year by year, Net Margin stood at 109.72% in 2022, then grew by 12bps to 96.17% in 2023, then surged by 40bps to 58.07% in 2024, then plummeted by -88bps to 109.09% in 2025, then fell by -22bps to 132.93% in 2026.
  • According to Business Quant data, Net Margin over the past three periods came in at 132.93%, 109.09%, and 0.14% for Q1 2026, Q4 2025, and Q3 2025 respectively.